| NDC Code | 59417-117-01 |
|---|
| Package Description | 100 TABLET, CHEWABLE in 1 BOTTLE (59417-117-01) |
|---|
| Product NDC | 59417-117 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Vyvanse |
|---|
| Non-Proprietary Name | Lisdexamfetamine Dimesylate |
|---|
| Dosage Form | TABLET, CHEWABLE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20170128 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA208510 |
|---|
| Manufacturer | Takeda Pharmaceuticals America, Inc. |
|---|
| Substance Name | LISDEXAMFETAMINE DIMESYLATE |
|---|
| Strength | 30 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE] |
|---|
| DEA Schedule | CII |
|---|